EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

Since 2001, EORTC and Kom op tegen Kanker have supported the EORTC RTQA fellowship programme, which has substantially contributed to the improvements of the radiation oncology field with a direct benefit not only to Belgian patients but also to all patients who participate in EORTC clinical trials.

For over 20 years, Fellowships have been empowering young scientists with a specific focus on radiation oncology, and its overarching aim is to enhance understanding, knowledge, and skills necessary for conducting successful clinical research.

In the realm of cancer research, the Emmanuel van der Schueren (EvdS) Fellowship Programme, supported by Kom op tegen Kanker, has been a centre of excellence since its inception in 2001.

The fellowship programme accompanied 15 accomplished fellows, each contributing substantially to the field. The output is not just measured in terms of numbers; it’s reflected in the 59 papers published by former fellows from 2001 to 2023. This wealth of scientific knowledge has a far-reaching impact on the improvement of patient care.

Former fellows, through a survey conducted by EORTC, reported that the programme significantly influenced their networking, career trajectory, and academic pursuits. The fellowship has become a stepping stone for these professionals, propelling them into influential roles in their home countries and beyond.

All fellows mention the fellowship bringing them closer to clinical trials from their daily clinical practice. Scientific collaborations and networking are mentioned as one of the cornerstones of their fellowship. Two fellows specifically named the fellowship has helped them acquire new positions in their home countries, while another fellow continued as an EORTC staff member.

The absence of such a fellowship would have a detrimental effect on the community of young radiation oncology researchers in Belgium and Europe. It plays a pivotal role in elevating the standards of radiation oncology, ensuring that clinical trials are conducted with precision, ultimately benefiting cancer patients across Europe.

EORTC remains grateful to Kom op tegen Kanker for its unwavering support, positioning itself as a European contributor to the progress of radiation oncology.

Support for the overall EORTC Fellowship Programme comes from several sources, including Kom op tegen Kanker, and more than 200 fellowships covering over 40 countries have been awarded since 1991.

Learn more about EORTC Fellowships.

Back to news list

Related News

  • EORTC: Advancing research and treatment for rare cancers

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)

  • EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)

  • Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023

  • EORTC Quality of Life measures integrated in CDISC

  • EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma

  • Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia

  • New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023

  • EORTC & the Menarini Group Launch New Clinical Trial in Early-Stage Breast Cancer